Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma a case report

Cancer

Volumn 91, Issue 8, 2001, Pages 1423-1428

  Prestigiacomo, Charles J ^a   Balmaceda, Casilda ^a   Dalmau, Josep ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Anti Ri autoantibody; Immunologic analysis; Preneoplastic syndrome; Transitional cell carcinoma

Indexed keywords

AUTOANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATAXIA; BLADDER CARCINOMA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOCLONUS; OPSOCLONUS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SEROLOGY; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING;

ANTIBODIES; ANTIGENS, NEOPLASM; ATAXIA; CARCINOMA, TRANSITIONAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; OCULAR MOTILITY DISORDERS; PARANEOPLASTIC SYNDROMES; RNA-BINDING PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 0035871399     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010415)91:8<1423::AID-CNCR1148>3.0.CO;2-F     Document Type: Article

References (33)

1. The remote effects of cancer on the nervous system
2. Value of the detection of anti-nervous system autoantibodies in neurologic paraneoplastic syndromes
3. Autoimmune paraneoplastic neurological syndromes
4. Paraneoplastic syndromes
5. Pathogenesis of central nervous system paraneoplastic syndromes
6. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma
7. Ocular involvement in neuroblastoma: Prognostic implications
8. Opsoclonus, myoclonus ataxia and encephalopathy in adults with cancer: A distinct paraneoplastic syndrome
9. An antineuronal autoantibody in paraneoplastic opsoclonus
10. Opsoclonus in adults: Report of 3 cases and review of the literature
11. Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer
12. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
13. Antigen unmasking on formalin-fixed paraffin- embedded tissue sections
14. The expression of the Hu (paraneoplastic encephalomyelitis/ sensory neuronopathy) antigen in human normal and tumor tissues
15. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: A long-term survey of ovarian cancer patients
16. Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature
17. Opsoclonus as the initial manifestation of occult neuroblastoma
18. Paraneoplastic neurological syndrome in transitional cell carcinoma of the bladder
19. Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and a review of the literature
20. Paraneoplastic syndromes in cancer of the bladder. Review of the literature
21. Paraneoplastic syndromes in urology
22. The neuronal nuclear antigen recognized by the anti-Ri autoantibody is expressed in the central but not peripheral nervous system neurons
23. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes
24. The expression of a neuronal nuclear antigen (Ri) recognized by the human anti-Ri autoantibody in the developing rat nervous system
25. Immunological and pathological study of anti-Ri associated encephalopathy
26. The neuronal RNA-binding protein Nova-2 is implicated as the-autoantigen targeted in POMA patients with dementia
27. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo
28. The antineural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies
29. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system
30. Chronic relapsing steroid sensitive ataxic syndrome in children with ganglioneuroblastoma
31. Antineuronal anti-Ri antibodies in a patient with steroid-responsive opsoclonus-myoclonus
32. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes
33. Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption